Motta, Irene
Bou-Fakhredin, Rayan
Taher, Ali T.
Cappellini, Maria Domenica
Article History
First Online: 15 June 2020
Compliance with Ethical Standards
:
: The preparation of this review was not supported by any external funding.
: RB has nothing to disclose. IM reports receiving honoraria from Sanofi-Genzyme. ATT reports receiving consultancy, research funding, and honoraria from Novartis; research funding and consultancy from Celgene; consultancy from Vifor, research funding from La Jolla, research funding and consultancy from Protagonist Therapeutics; consultancy from IONIS Pharmaceuticals. MDC reports receiving consultancy, research funding and honoraria from Novartis; research funding and consultancy from Celgene; consultancy from Vifor, research funding from La Jolla, research funding from Protagonist Therapeutics; consultancy from IONIS Pharmaceuticals, and research funding from CRISPR Therapeutics.
Free to read: This content has been made available to all.